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Fig. 1. Serum homocysteine values. (A) In
136 white patients on chronic dialysis (85 men,
51 women, age, 61  14 years) at baseline
(before any vitamin supplementation) and 6
months after vitamin supplementation (vita-
min B12, 1000 to 3000 g/week plus folic acid
15 mg/week). Patients bearing the TT geno-
type (N  22; 16%) and never treated with
vitamin therapies showed outstandingly higher
serum homocysteine values as compared with
patients with TC (N 67; 49%) and CC (N
48; 35%) genotypes. (B) Proportion of study
patients by dialysis period in 136 white patients
(85 males, 51 females, age 61  14 years) in
whom the duration of dialysis was 8.3  8.4
years (minimum 0.6 year, maximum 33 years).
Dialysis period is the year-subgroup of duration
of dialysis. The percentage of TT homozygous
in those with duration of dialysis of greater
than 20 years was higher (18%) than in those
with duration of dialysis 5 years (13%).
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general population has been demonstrated for body size
[2] and serum cholesterol [3] and has beeen postulated
to be due to malnutrition [3]. We agree with Canavese
et al that a great deal of research is still necessary regard-
ing the biological mechanisms of homocysteine metabo-
lism in patients with ESRD and their relationship to
cardiovascular risk.
The finding of differing TT genotype prevalence over
years of dialysis reported in these two studies is not irrec-
onciliable. There may be other differences in the design
of the studies that might explain variable risk estimates,
including clinical status, sample size, measurement issues,
Fig. 1. Time trends in evolution of lean body mass (LBM) after switchand race/ethnicity composition. We intend to examine
from conventional to daily hemodialysis in 7 patients with a 12-monthfollow-up data from our study and agree that experience
follow-up. It significantly increased within the first 6 months (P 0.02),reported from other centers is greatly needed. and remained stable thereafter. Value at t0 represents the average
Routine screening of either homocysteine or genetics between the values obtained at times 3 and 0, respectively. Mean
weekly ( SEM) standard Kt/V [2] increased from 2.22  0.13 atin not routinely recommended. A professional organiza-
baseline to 3.25  0.20 at 12 months (P  0.001).tion weighing the merits of such a clinical policy should
take into consideration the cost-effectiveness of the test
and associated interventions. In our clinic, the costs of
such tests are significantly lower than those mentioned
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Based on these observations, a switch to DHD could
be proposed to CHD patients with poor nutritional sta-
tus. Further studies, including a larger number of pa-
tients, are required to confirm these encouraging results.
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